In the 39 advanced NSCLC patients, we identified gene mutations, including EGFR, KRAS, PIK3CA, ALK and RET (Figure 3) and the sensitivity, specificity, PPV and NPV of detecting those mutations in ctDNA were illustrated in Table 4. The gene discussed is ALK; the disease is non-small cell lung carcinoma.